4//SEC Filing
ODINK DEBRA 4
Accession 0001104659-12-047526
CIK 0001316175other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 7:27 PM ET
Size
5.3 KB
Accession
0001104659-12-047526
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Tax Payment
Common Stock
2012-06-30$0.69/sh−1,838$1,268→ 24,821 total
Holdings
- 95,928(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
Related Parties
1- filerCIK 0001281719
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 7:27 PM ET
- Size
- 5.3 KB